| Overview |
| bs-10031r-cy3-100ul |
| CSN3 Polyclonal Antibody, Cy3 Conjugated |
| WB, IF(IHC-P) |
| Bovine, Cow |
| Sheep |
| Specifications |
| Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from bovine Kappa-casein |
| 111-170/190 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 281728 |
| P02668 |
| Secreted |
| CSNK; CSN10; Kappa-casein; CSN3 |
| Kappa-casein stabilizes micelle formation, preventing casein precipitation in milk. Casoxins A, B and C have opioid antagonist activity. Casoxin C causes biphasic ileal contractions through the binding to the complement C3a receptors. Casoplatelin inhibits platelet aggregation. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
Powered by Bioz